Novel agents for treating IgA nephropathy

U Kunter, C Seikrit, J Floege - Current Opinion in Nephrology and …, 2023 - journals.lww.com
Novel agents for treating IgA nephropathy : Current Opinion in Nephrology and
Hypertension Novel agents for treating IgA nephropathy : Current Opinion in Nephrology …

An update on corticosteroid treatment for IgA nephropathy

M Ghaddar, J Barratt, SJ Barbour - Current Opinion in Nephrology …, 2023 - journals.lww.com
An update on corticosteroid treatment for IgA nephropathy : Current Opinion in Nephrology
and Hypertension An update on corticosteroid treatment for IgA nephropathy : Current …

Understanding patient needs and predicting outcomes in IgA nephropathy using data analytics and artificial intelligence: a narrative review

FP Schena, C Manno, G Strippoli - Clinical Kidney Journal, 2023 - academic.oup.com
This narrative review explores two case scenarios related to immunoglobulin A nephropathy
(IgAN) and the application of predictive monitoring, big data analysis and artificial …

Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy

B Peters, J Beige, J Siwy, M Rudnicki… - Nephrology Dialysis …, 2023 - academic.oup.com
ABSTRACT Background Immunoglobulin A nephropathy (IgAN) frequently leads to kidney
failure. The urinary proteomics-based classifier IgAN237 may predict disease progression at …

Prognostic value of the albumin-to-fibrinogen ratio (AFR) in IgA nephropathy patients

A Qin, S Wang, L Dong, Z Jiang, D Yang, J Tan… - International …, 2022 - Elsevier
Background The albumin-to-fibrinogen ratio (AFR), a novel inflammatory marker, has been
studied in various diseases. However, whether AFR could act as a prognostic factor for IgAN …

[HTML][HTML] The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

M Vivarelli, J Barratt, LH Beck Jr, F Fakhouri, DP Gale… - Kidney International, 2024 - Elsevier
Uncontrolled complement activation can cause or contribute to glomerular injury in multiple
kidney diseases. While complement activation plays a causal role in atypical hemolytic …

A primer in precision nephrology: optimizing outcomes in kidney health and disease through data-driven medicine

P Jayaraman, A Crouse, G Nadkarni, M Might - Kidney360, 2023 - journals.lww.com
This year marks the 63rd anniversary of the International Society of Nephrology, which
signaled nephrology's emergence as a modern medical discipline. In this article, we briefly …

Machine learning-based diagnosis and prognosis of IgAN: A systematic review and meta-analysis

K Zhuang, W Wang, C Xu, X Guo, X Ren, Y Liang… - Heliyon, 2024 - cell.com
Purpose Plenty of studies have explored the diagnosis and prognosis of IgA nephropathy
(IgAN) based on machine learning (ML), but the accuracy lacks the support of evidence …

A bibliometric analysis of complement in IgA nephropathy from 1991 to 2022

Y Guo, H Zhang, X Yu - Frontiers in Pharmacology, 2023 - frontiersin.org
Introduction: IgA nephropathy is a common glomerular disease on a global scale, which has
resulted in significant economic burdens. The complement system plays a vital role in …

A new parameter predicting steroid response in idiopathic IgA nephropathy: a pilot study of pan-immune inflammation value

O Tunca, ED Kazan - 2022 - acikerisim.afsu.edu.tr
Objective: In this pilot study, we aimed at investigating the predictive power of pan-immune
inflammation value (PIV) on response rates at 6 months in idiopathic IgA nephropathy (IgAN) …